​

Funding Round

Series B - CancerIQ

Series B - CancerIQ

Investment Firm

Overview

CancerIQ provides a precision prevention platform that empowers community-based providers to prevent cancer.

Announced Date

Mar 03, 2022

Funding Type

Series B

Highlights

Location

United States, North America

Social

Investor Lead

Amgen Ventures

Amgen Ventures

Amgen Ventures is a early_stage_venture and late_stage_venture and seed and venture firm.

Merck Global Health Innovation Fund

Merck Global Health Innovation Fund

Merck Global Health Innovation Fund is a early_stage_venture and private_equity firm.

Participant Investors

4

Investor Name
Participant InvestorHealthX Ventures
Participant InvestorMerck Global Health Innovation Fund
Participant InvestorAmgen Ventures
Participant InvestorMcKesson Ventures

Round Details and Background

CancerIQ raised $14000000 on 2022-03-03 in Series B

CancerIQ provides a precision prevention platform that empowers community-based providers to prevent cancer.

Company Funding History

7

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Mar 03, 2022
Series B - CancerIQ
5-14.0M
Nov 10, 2023
Convertible Note - CancerIQ
1-undefined
Oct 13, 2014
Convertible Note - CancerIQ
1-1.2M
Jun 01, 2013
Seed Round - CancerIQ
1-undefined

Recent Activity

There is no recent news or activity for this profile.